Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Baruch Fischhoff a Department of
Social and Decision Sciences, Carnegie Mellon University, Pittsburgh,
PA 15213, USA, b Academic Department of Psychological Medicine, Guy's,
King's, and St Thomas's School of Medicine and Institute of
Psychiatry, London SE5 8AF Correspondence to: S Wessely s.wessely{at}iop.kcl.ac.uk
People need to rationalise their health problems, and those with
medical mysteries will find some explanation. The best way to manage
such patients is unclear, but the principles described in this article
should help improve the satisfaction of both patients and doctors
The causes of many health problems remain a mystery despite
the advances of modern medicine.1 When a medical
explanation is slow in coming, patients often infer that events (and
perhaps people) are responsible for their condition. They may then
judge harshly anyone who does not take their condition and inferences seriously. Physicians, officials, and companies often bear the brunt of
this anger.2 For example, in the controversies surrounding chronic fatigue syndrome, Gulf war sickness, and cancer clusters, authorities who denied sufferers' claims met with scorn and contempt.
Public unease, such as caused by the current threat of terrorism, is
likely to make medical mysteries more common.3 We therefore need a disciplined public health response for dealing with
inexplicable health effects. In this article, we discuss how illness
beliefs arise and suggest principles for dealing with patients.
Any widescale medical intervention will coincide with the
development of medically unexplained symptoms. The intervention may
then be seen as a putative cause.4 Currently, smallpox vaccinations are an obvious target for such attributions, given the
publicity surrounding them and their high level of side effects.
Patients naturally want explanations and treatments for their ill
health. Professionals, on the other hand, want to be sure about the
diagnosis before acting, fearing the monetary and health costs of
treating hypothetical conditions. But however justified hesitation may
be medically, it can seem callous to patients. They may begin to doubt
the integrity of doctors and see them as indifferent to their
plight.5
The ensuing anger of patients will add to the mutual misunderstanding.
No one wants to be distrusted. It is therefore only human for doctors
and scientists to want to pull back from a hostile public or to view
the public as foolish, uncomprehending, hysterical, or
malingering.6-8 If such professionals speak less, or less respectfully, to the public, their credibility may decline further. They may eventually avoid health problems associated with hostile patients, expensive lawsuits, and government inquiries. This allows opportunists to fill the void, fanning patients' discontent and hawking dubious remedies.9
The uncertainty surrounding each medical mystery reflects its unique
properties. However, these social and psychological dynamics occur in
other contexts where the stakes are high, the trade-offs difficult, and
the uncertainties large (such as many environmental conflicts).
6 8 10 11
We can use the experience from
these diverse crises to guide us in dealing with mysterious illnesses.
Communication is essential to maintain trust and credibility.
However, the window of opportunity is limited, especially with an
already stressed audience. Messages that seem irrelevant or disrespectful can make people less likely to listen, especially if
vital information seems to have been hidden. Doctors must focus on the
facts that matter most to patients, which requires thinking hard about
their predicament:
Summary points
Without a medical explanation, patients are likely to attribute
their illness to events
Terrorist threats are likely to increase the number of unexplained
health problems
Doctors need guidance to avoid alienating such patients
Communication should be focused on patients' concerns
Relief of symptoms should be the priority
Risks should be given numerically and scientific uncertainty
acknowledged
![]()
Development of illness beliefs
![]()
Focus communication around patients' concerns
Of course, few clinicians have the resources to conduct decision
analyses for individual patients. However, researchers could examine
recurrent issues in general form, summarising the scientific literature
(and its attendant uncertainties) in terms relevant to patients and
summarising common beliefs of patients in terms that are relevant to
doctors.10-15
| |
Organise the information coherently |
|---|
People can hold only about seven things in their mind at any one time.16 That may be too few for some complex medical problems. The way around this cognitive limit is "chunking," organising the information into coherent units. Creating such mental models enables people to integrate new information with existing beliefs and respond to new situations and claims.17 A good story also provides a narrative for explaining your condition and a feeling that progress is possible.18
|
| |
Give risk as numbers |
|---|
Professionals often use verbal quantifiers such as "rarely"
and "unlikely" to describe risk because they believe the public is
innumerate. Although such terms are an effective shorthand in familiar
situations ("It rarely rains in the summer here"), they can cause
confusion in unfamiliar ones (how frequent is a "rare" side
effect?).
19 20
Vague terms give no perspective on
experiences outside the normal range. To understand their risk of
infection in an anthrax attack, for example, people need to know both
the numerator (estimated number of casualties) and the denominator
(number of exposed people). Even if initially unfamiliar, quantitative
estimates of risk can (and must) acquire meaning through repeated
exposure. Although people prefer to express themselves in verbal terms,
they prefer the added precision of numbers from other
people.21 When they try to use numbers, most people seem to use them at least as well as verbal quantifiers.22
| |
Acknowledge scientific uncertainty |
|---|
Patients and policy makers may apply understandable pressure for clear answers. Yielding to that pressure is, however, a trap when scientific uncertainty is great. People note and remember when firm promises are violated by subsequent evidence, as has happened in the controversies over bovine spongiform encephalopathy and hormone replacement therapy. Such apparent violations of trust may open the door for less circumspect individuals to offer their own strong claims. When scientists overstate their case, it becomes harder for the public to distinguish science from non-science.23
Uncertainty need not mean paralysis. Rather it defines the gamble
associated with any action or inaction. Faced with the same uncertainties, people may prefer different gambles. It is therefore essential for them to know what their (uncertain) options
are.
12 14 24
| |
Use universally understood language |
|---|
We should all know to avoid polysyllabic jargon. Less obvious is avoiding everyday terms whose meaning varies across groups. Psychological diagnoses often do that. Objective medical descriptions, such as depression, carry negative connotations for many people. As with other areas of communication, there is no substitute for knowing your audience, which may require systematic, empirical study. 25 26
One challenge arises when patients have named their condition in
a way that leaves doctors uncomfortable, as occurred with chronic
fatigue syndrome. It may seem that adopting the lay label endorses the
implicit causal theory and reinforces the perceived disability.27 For better or worse, the medical profession
has lost the monopoly on naming conditions, and rejecting lay terms can
needlessly alienate patients.28 A compromise strategy is "constructive labelling," expanding on the lay name. It would mean
treating chronic fatigue syndrome as a legitimate illness, acknowledging that it may have a viral trigger (as many patients report), while gradually expanding understanding of the condition to
incorporate the psychological and social dimensions. The recent adoption by the UK Medical Research Council and the chief medical officer's report of the term chronic fatigue syndrome/myalgic encephalitis reflects such a compromise, albeit an uneasy
one.29
| |
Focus on relieving symptoms |
|---|
If patients feel better, explaining their condition becomes less
essential. Explanation is still important for satisfying curiosity,
improving the efficiency of treatment, and preventing future problems.
But these are all less urgent tasks and hence less stressful. Focusing
on symptoms shows compassion and responsibility. It allows doctors to
listen to patients' personal histories without having to evaluate
them. It reduces the risks of appearing disrespectful and the
associated conflict and stress.
30 31
Of course, if the
outcome cannot be guaranteed, treatment needs to be accompanied by
realistic assessments of the uncertainty surrounding it.2
| |
Unifying doctors' behaviour |
|---|
Translating principles into action is rarely straightforward. Doctors need protocols for dealing with potentially angry patients with mysterious conditions.14 The principles we have described above could be used to develop such a protocol. Any protocol should also include empirically evaluated examples of respectful responses to patients' concerns. Doctors could then use these examples to protect against the natural tendency to regress under pressure to a simplistic, intuitive response. In addition to its immediate benefits, each successful response to stressed patients increases the public goodwill that professionals will need in future crises.
Public goodwill and trust will be essential if the current threat of
terrorism is realised. Terrorists hope to create fear, confusion, and
distrust. In addition to direct injuries, chemical, biological, and
radiological weapons can produce mysterious symptoms, as can some
measures of prevention and treatment (such as mass vaccinations). The
Gulf war and public exposure to Agent Orange, sarin, and anthrax have
all produced such fallout. Each such crisis feeds off, and adds to, the
erosion of public trust in societal institutions. We can therefore
expect a continuing stream of medical mysteries. Our preparation for
these eventualities should include creating communication policies and
protocols that meet citizens' need to understand and manage their
health in deeply uncertain situations.
| |
Footnotes |
|---|
Competing interests: None declared
| |
References |
|---|
| 1. | Kroenke K, Price RK. Symptoms in the community: prevalence, classification, and psychiatric comorbidity. Arch Intern Med 1993; 153: 2474-2480[Abstract]. |
| 2. | Engel C, Adkins J, Cowan D. Caring for medically unexplained physical symptoms after toxic environmental exposures: effects of contested causation. Environ Health Perspect 2002; 110(suppl 4): 641-647[Medline]. |
| 3. |
Hassett A, Sigal L.
Unforeseen consequences of terrorism: medically unexplained symptoms in a time of fear.
Arch Intern Med
2002;
162:
1809-1813 |
| 4. | Kahneman D, Tversky A, Slovic C, eds. Judgment under uncertainty: heuristics and biases. New York: Cambridge University Press, 1982. |
| 5. | Mechanic D. The functions and limitations of trust in the provision of medical care. J Health Polit Policy Law 1998; 23: 661-686[ISI][Medline]. |
| 6. | Fischhoff B. Risk perception and communication unplugged: twenty years of process. Risk Analysis 1995; 15: 137-145[CrossRef][ISI][Medline]. |
| 7. | Lupton D. Risk. New York: Routledge, 1999. |
| 8. | Powell D, Leiss W. Mad cows and mother's milk. Montreal: McGill-Queens, 1997. |
| 9. |
Deyo R, Psaty B, Simon G, Wagner E, Omenn G.
The messenger under attack intimidation of researchers by special interest groups.
N Engl J Med
1997;
336:
1176-1180 |
| 10. | Slovic P, ed. Perception of risk. London: Earthscan, 2001. |
| 11. | Fischhoff B. Why (cancer) risk communication can be hard. J Natl Cancer Inst Monogr 1999; 25: 7-13. |
| 12. | Bursztajn H, Feinbloom RI, Hamm RM, Brodsky A. Medical choices, medical chances. New York: Dell, 1981. |
| 13. | Fischhoff B, Bostrom A, Quadrel MJ. Risk perception and communication. In: Detels R, McEwen J, Beaglehole R, Tanaka H, eds. Oxford textbook of public health. London: Oxford University Press, 2002:1105-1123. |
| 14. | Fischhoff B. Giving advice: Decision theory perspectives on sexual assault. Am Psychol 1992; 47: 577-588[CrossRef][Medline] |
| 15. | Byram S, Fischhoff B, Embrey M, Bruine de Bruin W, Thorne S. Mental models of women with breast implants regarding local complications. Behav Med 2001; 27: 4-14[ISI][Medline]. |
| 16. | Miller GA. The magical number seven, plus or minus two: some limits on our capacity for processing information. Psychol Rev 1956; 63: 81-97[CrossRef][ISI][Medline]. |
| 17. | Morgan MG, Fischhoff B, Bostrom A, Atman C. Risk communication: the mental models approach. New York: Cambridge University Press, 2001. |
| 18. | Pennebaker JW. Telling stories: the health benefits of narrative. Lit Med 2000; 19: 3-18[ISI][Medline]. |
| 19. | Wallsten TS, Budescu DV, Rapoport A, Zwick R, Forsyth B. Measuring the vague meanings of probability terms. J Exp Psychol Gen 1986; 115: 348-365[CrossRef]. |
| 20. | Schwarz N. Self reports. Am Psychol 1999; 54: 93-105. |
| 21. | Budescu DF, Wallsten TS. Processing linguistic probabilities: general principles and empirical evidence. In: Busemeyer JR, Hastie R, Medin DL, eds. Decision making from the perspective of cognitive psychology. New York: Academic Press, 1995:275-318. |
| 22. |
Woloshin S, Schwartz LM, Byram S, Fischhoff B, Welch HG.
A new scale for assessing perceptions of chance: a validation study.
Med Decision Making
2000;
20:
298-307 |
| 23. | Gilovich T. How we know what isn't so. New York: Free Press, 1993. |
| 24. | McNeil BJ, Weichselbaum MD, Pauker SG. Fallacy of the five-year survival rate in lung cancer. N Engl J Med 1978; 289: 1397-1401. |
| 25. | Furnham A. Lay theories. New York: Oxford University Press, 1987. |
| 26. | Komaroff AL. The variability and inaccuracy of medical data. Proceedings of the Institute of Electrical and Electronics Engineers 1979; 67(9): 17-27. |
| 27. | Finestone AJ. A doctor's dilemma. Is a diagnosis disabling or enabling? Arch Intern Med 1997; 157: 491-492[CrossRef][ISI][Medline]. |
| 28. | Jason L, Taylor R, Stepanek Z, Plioplys S. Attitudes regarding chronic fatigue syndrome: the importance of a name. J Health Psychol 2001; 6: 61-71[Abstract]. |
| 29. | Sharpe M. The English chief medical officer's working parties' report on the management of CFS/ME: significant breakthrough or unsatisfactory compromise? J Psychosom Res 2002; 52: 437-438[CrossRef][ISI][Medline]. |
| 30. | Hartz A, Noyes R, Bentler SE, Damiano PC, Willard JC, Momany ET. Unexplained symptoms in primary care: perspectives of doctors and patients. Gen Hosp Psychiatry 2000; 22: 144-152[CrossRef][ISI][Medline]. |
| 31. | Van Dulmen A, Fennis J, Mokkink HG, Van der Velden HG, Bleijenberg G. Doctor-dependent changes in complaint-related cognitions and anxiety during medical consultations in functional abdominal complaints. Psychol Med 1995; 25: 1011-1018[ISI][Medline]. |
(Accepted 27 January 2003)
Read all Rapid Responses
UK medical students have published unreleased government plans to restrict failed asylum seekers' access to medical care